Evidence map›Paper›PMID 36829930›Full record

ArticleAntioxidants (Basel, Switzerland)2023

β Boswellic Acid Blocks Articular Innate Immune Responses: An In Silico and In Vitro Approach to Traditional Medicine.

Eloi Franco-Trepat, Ana Alonso-Pérez, María Guillán-Fresco, Miriam López-Fagúndez, Andrés Pazos-Pérez, Antía Crespo-Golmar, Susana Belén Bravo, Verónica López-López, Alberto Jorge-Mora, José P Cerón-Carrasco and 2 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Advances in Drug Delivery Systems for Boswellic Acids fromInternational journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. A full-spectrumFrontiers in pharmacology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Eloi Franco-TrepatMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-7514-4672
Ana Alonso-PérezMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-5830-0960
María Guillán-FrescoMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-6269-5130
Miriam López-FagúndezMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-4577-737X
Andrés Pazos-PérezMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-8598-9476
Antía Crespo-GolmarMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.
Susana Belén BravoMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.
Verónica López-LópezMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.
Alberto Jorge-MoraMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.
José P Cerón-CarrascoCentro Universitario de la Defensa, Universidad Politécnica de Cartagena, C/Coronel López Peña S/N, Base Aérea de San Javier, Santiago de La Ribera, 30720 Murcia, Spain.ORCID 0000-0003-0668-9227
Ana Lois IglesiasMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.
Rodolfo GómezMusculoskeletal Pathology Group, Institute IDIS, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.ORCID 0000-0002-1309-1023
Instituto de Investigación Sanitaria de Santiago · ESUniversidad Politécnica de Cartagena · ES

Funding

European Union's Horizon Europe research and innovation programme: ENDOTARGET 101095084Fundación Española de Reumatologia (FER) Búsqueda de nuevos fármacos bloqueantes de la inflamación asociada a TLR4 en condrocitos humanos Artrósicos (Artrosis 2019)Fundación Mutua Madrileña MMA 2018Fundación Mutua Madrileña MMA 2020Instituto de Salud Carlos III & FEDER CM20/00186Instituto de Salud Carlos III & FEDER CP15/00007Instituto de Salud Carlos III & FEDER CPII20/00026Instituto de Salud Carlos III & FEDER FI20/00210Instituto de Salud Carlos III & FEDER PI16/01870Instituto de Salud Carlos III & FEDER PI19/01446Instituto de Salud Carlos III & FEDER PT20/00009Instituto de Salud Carlos III & FEDER RD21/0002/0025Spanish Ministry of Science via FECYT PRECIPITA PR250Spanish Ministry of Universities FPU17/01706Spanish Ministry of Universities & European Union through NextGenerationEU UDC Margarita Salas RSU.UDC.MS06
6 · The paper itself

Abstract

Osteoarthritis (OA) is hallmarked as a silent progressive rheumatic disease of the whole joint. The accumulation of inflammatory and catabolic factors such as IL6, TNFα, and COX2 drives the OA pathophysiology into cartilage degradation, synovia inflammation, and bone destruction. There is no clinical available OA treatment. Although traditional ayurvedic medicine has been using

Indexed as

chondrocytesIL1NLRP3osteoarthritisROSsynoviocytesTLR4

Identifiers

PMID36829930
PMCPMC9952103
OpenAlexW4319316197

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.